Shares of Titan Pharmaceuticals Inc. (OTC: TTNP), a biopharmaceutical company engaged in the development of proprietary therapeutics mainly for the treatment of central nervous system disorders, are seeing a huge rally in today’s trading after the company provided an update on its Probuphine™. At last check, Titan Pharmaceuticals shares were trading 18.11% higher at $1.50, [...]
User Profile
- Username mr.moneymaker
- Member since 2010-04-26 14:10:24
- Number of published article60 articles
Articles published by mr.moneymaker
Checkpoint Shares plunge on Company’s Expanded Restructuring Plan; updates Financial Guidance
Shares of Checkpoint Systems Inc. (NYSE: CKP) are sinking in today’s trading after the company announced details of its expanded global SG&A and manufacturing plan and updated financial guidance for the full year. The company also provided financial guidance for the third quarter of 2011. Checkpoint shares fell to a new 52-week low of $10.58 [...]
Halozyme Therapeutics surges, leading Small-cap Biopharms
Shares of Halozyme Therapeutics Inc. (NASDAQ: HALO), a biopharmaceutical company focusing on the development and commercialization of recombinant human enzymes, are seeing a huge rally in today’s trading after the company announced positive results from subcutaneous Herceptin phase 3 trial conducted by Roche. Halozyme shares reached a high of $7.60 in mid-day trading, and at [...]
Tech Stock Trade Review; AAPL, RIMM, S
Apple Inc. (NASDAQ: AAPL) finally launched the latest version of the iPhone, the iPhone 4S smartphone. The new iPhone 4S includes a new camera and processor; however, it is mostly similar to the model the company has been selling for over a year now. The price for the latest device has been set at $199 [...]
YRC Worldwide Shares nudge Higher
YRC Worldwide Inc. (NASDAQ: YRCW), a holding company offering customers a range of transportation services, earlier in the week announced changes to its corporate organization structure. Shares were slightly up in today’s trade, closing up nearly 1% to $0.05. YRC, which has been trying to avert a bankruptcy, announced the appointments of Jeff Rogers as [...]
3 Trending Casino, Resort Stocks: MGM, Wynn, Carnival
MGM Resorts International (NYSE: MGM) shares rose in today’s trading. The stock finished the day 1.38% higher at $11.03, with volume up from daily average of 26.48 million to 31.03 million. MGM Resorts shares rose after Morgan Stanley raised its rating on the company’s shares from Equal Weight to Overweight. Wynn Resorts Limited (NASDAQ: WYNN) [...]
Biotech Stock on the Move; Vermillion surges on Positive Data
Many of our members are making big gains off this stock – sign up for our free e-mail alerts! Shares of Vermillion Inc. (NASDAQ: VRML), a biotechnology company engaged in the discovery, development and commercialization of diagnostic tests, are seeing a huge rally in today’s trading after the company presented data showing the improvement in [...]
OTC Stock Alert – Atlas Capital goes Green, Shares sink into Red
Atlas Capital Holdings Inc. (OTC: ALCL) shares dropped more than 15% this morning, weighed down by an announcement earlier this week that it signed a Letter of Intent (LOI) to acquire 100% of the shares of Textraw Inc., a developer and distributor of environmentally-friendly green synthetic ground cover manufactured from recycled materials. Peter Klaich, COO [...]
Top OTC Gainer; SavWatt plows through Friday Trade to close in the Green
SavWatt USA Inc. (OTC: SAVW) shares rocketed to more than 25% gains on the day after the company announced that it signed an exclusive agreement with P2i to make its LED lights water and dirt resistant. At last check, SavWatt shares were trading 12.50% higher at $0.0018, with volume up from daily average of 100.07 [...]
Biotech Stock on the Move: Opexa Therapeutics
Shares of Opexa Therapeutics Inc. (NASDAQ: OPXA) soared more than 20% today with no news to spur the trading, though message-board banter centers on the likelihood of positive news after the closing bell (not confirmed). Opexa is a Texas-based development-stage biopharm company focusing on the development of personalized cellular therapies with the potential to treat [...]